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Book Review
Hope, J. 2008. Biobazaar: The Open Source Revolution and Biotechnology, 
Cambridge, MA: Harvard University Press.
Reviewed by Maria-Jose Iglesias, Research Centre on IT and Law (CRID), 
University of Namur.
Is there any hope for a paradigm shift in biotechnologies? 
“Biobazaar – the open source revolution and biotechnology”, proposes the 
translation of the open source software model to the biotechnology. It explores 
whether and how key open source principles of technology development, 
licensing and commercialisations may be adapted and applied to biotechnology. 
It dismantles the theoretical assumption of intellectual property rights as being the 
best tool to induce innovation and pleads for the application of a science-friendly 
approach to be used in life sciences. 
The author, the Australian biologist and lawyer Jane Hope, acknowledges that 
such translation is not straightforward. The specific characteristics of the biotech 
sector – from the high investments or funding needs to the bundle of intellectual 
property rights (and other rights) to be considered, the relationship between 
innovators and other industry agents or the expertise required to participate in 
biotech research activities – may require some nuances on the adaptation of the 
open source principles. 
Bazaar mode of production is not new neither strange to biotechnology. 
Historically it has been adopted by traditional academics or in public funded, 
non-profit research activities. The main challenge is precisely to give convincing 
reasons to implement this model to for-profit or commercial initiatives. This is, 
no doubt, the main obstacle to overcome when drafting the whole proposition of 
the biobazaar. The author considers the feasibility of the use of open source mode 
of production in biotechnology commercial activities and gives strategic reasons 
to sustain it. She illustrates the possibilities and main points to take into account 
by commercial actors when considering the trade-off between proprietary and 
non-proprietary solutions. Despite her thorough discourse, one has the impression 
that concerning this crucial point, her propositions remain still in the surface, 
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that there is still a long way until we know whether commercial open source 
ventures in biotechnologies may become a reality. Nevertheless, it is true that 
there have been some attempts to conciliate private interests and open access. The 
author reports on the handful of open initiatives in the biotech sector – i.e., the 
General Public Licence for Plant Germplasm, the (abandoned) HapMap policy, 
the Biological Materials Transfer Project of Science Commons or the Biological 
Innovation for Open Society (BIOS) – (unfortunately she does not take too much 
into account the “access and benefit sharing” initiatives already in place in this 
sector). Open source biotechnologies are still at an early stage, but, clearly, they 
represent a hope for the forthcoming years. Key sectors such as agriculture or 
health, may suffer from the existing full proprietary approaches that not only harm 
the scientific research but impede the implementation of solutions for “some of 
humanity’s most pressing problems”. This book is an indispensable tool for those 
envisaging a paradigm shift, those thinking on workable fair licensing solutions 
in biotechs. 
